The recent AHA meetings have provided a littany of articles to look at, with the most recent coming in an online first form over at the New England Journal of Medicine. This topic however has been looked at before (ASTRAL and STAR), and now this new trial titled CORAL aims to put the argument to bed once and for all.
There was no significant difference between medical therapy (using ARB +/- thiazide, with amlodipine for blood pressure control) and stenting, when it comes to atherosclerotic renal artery stenosis. It is important to note that this doesn’t include those with fibromuscular dysplasia, a group who may do better with stenting.
source | New England Journal of Medicine
image | Wikimedia Commons